MetaCap

NewGenIvf Group Limited Class A (NIVF)

NASDAQ: NIVFHealth CareMisc Health and Biotechnology ServicesUSD

0.0269-0.0081 (-23.14%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NIVF stock chart

Technical analysis

Key statistics

All statistics
Market cap
$80.77K
EPS (TTM)
-$34,064.71
52-week range
0.0229 – 7,257.60
Day range
0.0229 – 0.0309
Volume / Avg
270.77M / 6.57M
Beta
—

52-week range

$0.0229$7,257.60

NIVF stock today

Shares of NewGenIvf Group (NIVF) finished lower on Nov 20 at $0.0269, a drop of 23.14% or $0.0081 per share, versus the S&P 500's 3.70% decline. Volume was 41.2x the average at 270.77M shares, a sign of unusually heavy trading. Shares are 100.0% below their 52-week high of $7,257.60 and 17.5% above the 52-week low of $0.0229, near the bottom of the past year's range.

NewGenIvf Group has posted a net loss over the last twelve months (EPS of -$34,064.71), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About NewGenIvf Group

Company profile

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment.

Industry
Misc Health and Biotechnology Services
CEO
Mr. Wing Fung Siu
Headquarters
Bangkok
Employees
87

Financial highlights

Full financials

In fiscal 2025, NewGenIvf Group generated $4.7 million in revenue, down 13.0% from fiscal 2024, its first annual decline since 2023. Net income was $9.9 million, for a net margin of 209.0% versus a median of 1.3% in the prior 4 years. Gross margin was 20.2% (down from 33.6%) and operating margin -226.9%.

NewGenIvf Group annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$4.73M$5.43M$5.14M$5.94M$4.12M
Growth-13.01%+5.79%-13.59%+44.34%—
Net income$9.88M$-524.64K$130.19K$458.67K$-533
EPS (diluted)$3.04$-4,408.76$13,019.30$4.72$0.00

Analyst forecast

Forecast

Consensus

none

Avg. price target

$127.08+472316.36%

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

NIVF news

All NIVF news

NewGenIvf Group peers

Health Care sector
NIVF peer companies
CompanyPrice% ChgMarket capCompare
MGRXMangoceuticals Inc.0.1236-7.55%$2.75Mvs NIVF
CCELCryo-Cell International Inc.4.150.00%$33.46Mvs NIVF
PARKPark Dental Partners Inc.17.03-6.79%$94.26Mvs NIVF
VMDViemed Healthcare Inc.8.52-1.05%$322.85Mvs NIVF
AGLagilon health inc.90.24+0.83%$1.52Bvs NIVF
PGNYProgyny Inc.35.71+0.73%$2.63Bvs NIVF
SHCSotera Health Company15.91-1.85%$4.54Bvs NIVF
DVADaVita Inc.161.03+3.00%$10.13Bvs NIVF

Indexes, lists and sector

NewGenIvf Group stock FAQ

What is NewGenIvf Group's stock price today?

NIVF last traded at $0.0269 as of Nov 20, 4:00 PM EST, down 23.14% on the day. Prices are delayed at least 15 minutes.

Does NewGenIvf Group pay a dividend?

No. NewGenIvf Group does not currently pay a regular cash dividend.

Who is NewGenIvf Group's CEO?

Mr. Wing Fung Siu is the chief executive officer of NewGenIvf Group Limited Class A, which has about 87 employees.

Has NIVF ever split its stock?

Yes. The most recent NIVF stock split was a 1-for-8 split on Oct 23, 2026, one of 2 splits on record.

What is the NIVF 52-week high?

The 52-week high for NIVF is $7,257.60 and the 52-week low is $0.0229. The stock is currently 100.0% below its high.

Compare NIVF